Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0049 | 0.0063 | 0.0063 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0049 | 0.0063 | 0.0063 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0051 | 0.0167 | 0.0589 |
Echinococcus multilocularis | Glycoside hydrolase, family 27 | 0.01 | 0.2832 | 0.271 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0051 | 0.0167 | 0.0167 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0061 | 0.0732 | 0.5 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.01 | 0.2832 | 1 |
Brugia malayi | hypothetical protein | 0.0094 | 0.2517 | 0.2517 |
Loa Loa (eye worm) | hypothetical protein | 0.0067 | 0.1035 | 0.0978 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0051 | 0.0167 | 0.0104 |
Schistosoma mansoni | eyes absent homolog | 0.0094 | 0.2517 | 0.8889 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0061 | 0.0732 | 0.2585 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0051 | 0.0167 | 0.0589 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.01 | 0.2832 | 1 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.01 | 0.2832 | 1 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0061 | 0.0732 | 0.2585 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0067 | 0.1035 | 0.3654 |
Toxoplasma gondii | melibiase subfamily protein | 0.01 | 0.2832 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0233 | 1 | 1 |
Trichomonas vaginalis | alpha-galactosidase/alpha-N-acetylgalactosaminidase, putative | 0.0067 | 0.1035 | 0.5 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.0067 | 0.1035 | 0.3654 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0061 | 0.0732 | 0.5 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0233 | 1 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0051 | 0.0167 | 0.0589 |
Schistosoma mansoni | alpha-galactosidase/alpha-n-acetylgalactosaminidase | 0.01 | 0.2832 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0061 | 0.0732 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0094 | 0.2517 | 0.247 |
Echinococcus multilocularis | Alpha N acetylgalactosaminidase | 0.01 | 0.2832 | 0.271 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0233 | 1 | 1 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0061 | 0.0732 | 0.0575 |
Echinococcus granulosus | Alpha N acetylgalactosaminidase | 0.01 | 0.2832 | 0.271 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0061 | 0.0732 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0094 | 0.2517 | 0.247 |
Brugia malayi | Melibiase family protein | 0.0067 | 0.1035 | 0.1035 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0061 | 0.0732 | 0.5 |
Onchocerca volvulus | 0.0048 | 0 | 0.5 | |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0061 | 0.0732 | 0.0575 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 2.9362 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.